A comprehensive strategy sets the stage for a new phase at SGC

We have brought together the recommendations of a working group composed of experts from the public and private sectors on how to best benefit from recent advances in AI and how to generate, format and disseminate data to enable future breakthroughs in AI-guided drug discovery.